TP53 and melanoma: The findings showed that P53 and γH2AX expression increased significantly after VB1 treatment and that the expression of Ki67 was inhibited (Additional file 3: Figure S3D), which was consistent with the results of the VB1 inhibition of xenografted melanoma cell growth (Fig. 2d) and induction of DNA damage.